Phagos is a French biotechnology startup founded in 2021. It develops a sustainable alternative to antibiotics based on bacteria’s natural predator, the bacteriophage. With over €4.5M in funding from both the public (BpiFrance) and private sectors (Hoxton Ventures, Demeter, Entrepreneur First, Agfunder, Dhyan VC), Phagos has produced a scalable personalized phage therapy platform to dispatch its solution globally.